Bibliography


Aksoy B et al (2010). The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities, BJD, 163: 719-725.

Belkert FC et al (2012). Willingness to pay and quality of life in patients with rosacea, JEADV, 27: 734-738.

Del Rosso JQ et al (2014). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea, Cutis, 93(3):134-138.

Del Rosso JQ et al (2014). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies, Cutis, 93(1):18-28.

Del Rosso JQ et al (2013). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents, Cutis, 92(6):277-284.

Del Rosso JQ et al (2013). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care, Cutis, 92(5):234-240.

Elewski BE et al (2011). Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group, JEADV, 25(2):188-200.

Fowler J et al (2013). Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized double-blind, vehicle-controlled pivotal studies, JDD, 12(6): 650-656.

Fowler J et al (2012). Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicenter, randomized and vehicle-controlled studies, BJD, 166:633-641.

Gold LS et al (2014). Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies, J Drugs Derm, 13(3): 316-323.

Hsu CC et al (2012) Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective beta-adrenergic blocker, JAAD, 67: 128-135.

Taieb A et al (2014). Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial, BJD, Epub ahead of print.

Tanghetti E et al (2014). Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 4: a status report on physical modalities and devices, Cutis, 93(2):71-76.

Weinstock LB, Steinhoff M (2013). Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin, JAAD, 68:875-876.